Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biontech Se ADR (BNTX)

Biontech Se ADR (BNTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 29,409,602
  • Shares Outstanding, K 240,786
  • Annual Sales, $ 550,960 K
  • Annual Income, $ 17,360 K
  • 60-Month Beta -1.92
  • Price/Sales 50.04
  • Price/Cash Flow 420.42
  • Price/Book 16.53
Trade BNTX with:

Options Overview

Details
  • Implied Volatility 52.50%
  • Historical Volatility 59.38%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 185.26% on 06/18/20
  • IV Low 52.50% on 04/09/21
  • Put/Call Vol Ratio 1.66
  • Today's Volume 10,793
  • Volume Avg (30-Day) 5,416
  • Put/Call OI Ratio 0.68
  • Today's Open Interest 56,003
  • Open Int (30-Day) 47,585

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 2.66
  • Number of Estimates 4
  • High Estimate 4.80
  • Low Estimate 0.20
  • Prior Year -0.26
  • Growth Rate Est. (year over year) +1,123.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
92.93 +31.43%
on 03/25/21
123.50 -1.10%
on 04/09/21
+25.66 (+26.60%)
since 03/09/21
3-Month
90.29 +35.28%
on 03/08/21
123.50 -1.10%
on 04/09/21
+21.75 (+21.67%)
since 01/08/21
52-Week
37.00 +230.11%
on 04/16/20
131.00 -6.76%
on 12/11/20
+76.73 (+168.97%)
since 04/09/20

Most Recent Stories

More News
The Latest: Lawmakers aim to limit state emergency powers

NEW YORK — State lawmakers across the U.S. are taking actions to limit the emergency powers of governors — not just in the current coronavirus pandemic, but for any future emergencies.

PFE : 36.60 (+1.78%)
JNJ : 161.25 (-1.06%)
BNTX : 122.14 (+6.68%)
The Latest: Navajo Nation issues weekend stay-at-home order

WINDOW ROCK, Ariz. -- The Navajo Nation has issued a stay-at-home order for the weekend after reporting 26 more confirmed COVID-19 cases.

JNJ : 161.25 (-1.06%)
PFE : 36.60 (+1.78%)
BNTX : 122.14 (+6.68%)
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus

Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.

AZN : 49.94 (+0.89%)
PFE : 36.60 (+1.78%)
MRNA : 140.92 (+5.26%)
NVAX : 179.74 (+1.97%)
IBB : 148.73 (-0.44%)
XBI : 129.63 (-2.22%)
BBH : 176.92 (+0.43%)
FBT : 158.84 (-0.46%)
BTEC : 57.06 (-0.24%)
BNTX : 122.14 (+6.68%)
AstraZeneca (AZN) COVID-19 Jab May Have Link to Rare Blood Clots

European regulators find a possible link between AstraZeneca's (AZN) COVID-19 vaccine and rare blood clot events.

AZN : 49.94 (+0.89%)
PFE : 36.60 (+1.78%)
MRNA : 140.92 (+5.26%)
BNTX : 122.14 (+6.68%)
Dow, Gibraltar Industries, Pfizer, BioNTech and Micron highlighted as Zacks Bull and Bear of the Day

Dow, Gibraltar Industries, Pfizer, BioNTech and Micron highlighted as Zacks Bull and Bear of the Day

MU : 95.30 (+0.01%)
PFE : 36.60 (+1.78%)
DOW : 63.14 (-0.08%)
ROCK : 89.53 (+3.46%)
BNTX : 122.14 (+6.68%)
Pfizer (PFE)/BioNTech COVID-19 Vaccine 100% Effective in Teens

Pfizer (PFE) and BioNTech (BNTX) report 100% efficacy for their COVID-19 vaccine in teenagers aged 12 to 15.

JNJ : 161.25 (-1.06%)
PFE : 36.60 (+1.78%)
MRNA : 140.92 (+5.26%)
BNTX : 122.14 (+6.68%)
Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced updated topline results from analysis of 927 confirmed symptomatic cases of COVID-19 observed in their pivotal Phase 3 study through...

PFE : 36.60 (+1.78%)
BNTX : 122.14 (+6.68%)
Dow Dips, Other Markets Up for the Day; Micron (MU) Beats

Micron Technologies (MU), a Zacks Rank #1 (Strong Buy) memory and data storage giant, posted a modest beat on both top and bottom lines in its fiscal Q2 earnings.

MU : 95.30 (+0.01%)
PFE : 36.60 (+1.78%)
BNTX : 122.14 (+6.68%)
ETFs to Shine on Pfizer's Impressive COVID-19 Vaccine Update

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.

PFE : 36.60 (+1.78%)
MRNA : 140.92 (+5.26%)
IHE : 175.58 (+0.37%)
FDL : 33.17 (+0.64%)
FTXH : 25.46 (+0.29%)
IEIH : 31.99 (+0.31%)
BNTX : 122.14 (+6.68%)
Thinking about trading options or stock in BioNTech, Apple, Moderna, General Motors, or Nio?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNTX, AAPL, MRNA, GM, and NIO.

AAPL : 132.99 (+2.02%)
BNTX : 122.14 (+6.68%)
MRNA : 140.92 (+5.26%)
GM : 60.16 (+0.12%)
NIO : 38.12 (-1.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.

See More

Key Turning Points

3rd Resistance Point 134.30
2nd Resistance Point 128.90
1st Resistance Point 125.52
Last Price 122.14
1st Support Level 116.74
2nd Support Level 111.34
3rd Support Level 107.96

See More

52-Week High 131.00
Last Price 122.14
Fibonacci 61.8% 95.09
Fibonacci 50% 84.00
Fibonacci 38.2% 72.91
52-Week Low 37.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar